Levi S. Downs

7.4k total citations · 3 hit papers
80 papers, 4.9k citations indexed

About

Levi S. Downs is a scholar working on Obstetrics and Gynecology, Reproductive Medicine and Oncology. According to data from OpenAlex, Levi S. Downs has authored 80 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Obstetrics and Gynecology, 30 papers in Reproductive Medicine and 29 papers in Oncology. Recurrent topics in Levi S. Downs's work include Endometrial and Cervical Cancer Treatments (31 papers), Cervical Cancer and HPV Research (25 papers) and Ovarian cancer diagnosis and treatment (23 papers). Levi S. Downs is often cited by papers focused on Endometrial and Cervical Cancer Treatments (31 papers), Cervical Cancer and HPV Research (25 papers) and Ovarian cancer diagnosis and treatment (23 papers). Levi S. Downs collaborates with scholars based in United States, Canada and Switzerland. Levi S. Downs's co-authors include Shalini Kulasingam, Eduardo L. Franco, Debbie Saslow, Francisco García, Herschel W. Lawson, Ann Moriarty, Evan R. Myers, Mark H. Stoler, Joanna M. Cain and Maureen Killackey and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer.

In The Last Decade

Levi S. Downs

80 papers receiving 4.7k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer

2012 1.0k citations Debbie Saslow, Diane Solomon et al. CA A Cancer Journal for Clinicians profile →
American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology Screening Guidelines for the Prevention and Early Detection of Cervical Cancer

2012 745 citations Debbie Saslow, Diane Solomon et al. profile →
American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology Screening Guidelines for the Prevention and Early Detection of Cervical Cancer

2012 613 citations Debbie Saslow, Diane Solomon et al. American Journal of Clinical Pathology profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Levi S. Downs	2.8k	1.7k	1.4k	946	577	80	4.9k
Ruud L.M. Bekkers	2.9k 1.0×	1.3k 0.8×	1.3k 0.9×	1.4k 1.5×	786 1.4×	209	4.8k
Groesbeck P. Parham	2.3k 0.8×	2.3k 1.3×	721 0.5×	702 0.7×	404 0.7×	160	4.8k
Mario Sideri	2.8k 1.0×	855 0.5×	1.6k 1.2×	1.3k 1.4×	788 1.4×	108	4.2k
Karl Ulrich Petry	3.3k 1.2×	1.1k 0.6×	1.6k 1.2×	574 0.6×	291 0.5×	101	4.3k
Christine Bergeron	3.5k 1.3×	999 0.6×	1.7k 1.2×	1.2k 1.3×	1.1k 1.9×	99	5.1k
Theo J.M. Helmerhorst	3.8k 1.4×	1.1k 0.6×	1.8k 1.3×	664 0.7×	265 0.5×	85	5.2k
Shalini Kulasingam	5.0k 1.8×	2.1k 1.2×	2.0k 1.5×	1.1k 1.1×	528 0.9×	122	6.5k
Johan Bulten	2.7k 1.0×	1.1k 0.7×	1.6k 1.2×	1.7k 1.8×	1.3k 2.3×	206	5.4k
Patrick Petignat	2.0k 0.7×	1.1k 0.6×	1.0k 0.8×	919 1.0×	920 1.6×	233	4.3k
Sophie Derchain	1.3k 0.5×	957 0.6×	830 0.6×	595 0.6×	687 1.2×	218	3.5k

Countries citing papers authored by Levi S. Downs

Since Specialization

Citations

This map shows the geographic impact of Levi S. Downs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Levi S. Downs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Levi S. Downs more than expected).

Fields of papers citing papers by Levi S. Downs

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Levi S. Downs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Levi S. Downs. The network helps show where Levi S. Downs may publish in the future.

Co-authorship network of co-authors of Levi S. Downs

This figure shows the co-authorship network connecting the top 25 collaborators of Levi S. Downs. A scholar is included among the top collaborators of Levi S. Downs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Levi S. Downs. Levi S. Downs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Downs, Levi S., et al.. (2023). Implementation in action: Collaborating on the transition to primary HPV screening for cervical cancer in the United States. CA A Cancer Journal for Clinicians. 73(5). 458–460. 7 indexed citations

Dickson, Elizabeth L., Melissa A. Geller, Rachel I. Vogel, et al.. (2017). Enhanced Recovery Program and Length of Stay After Laparotomy on a Gynecologic Oncology Service. Obstetrics and Gynecology. 129(2). 355–362. 43 indexed citations

Felix, Ashley S., Louise A. Brinton, D. Scott McMeekin, et al.. (2015). Relationships of Tubal Ligation to Endometrial Carcinoma Stage and Mortality in the NRG Oncology/Gynecologic Oncology Group 210 Trial. Obstetrical & Gynecological Survey. 70(10). 624–626. 2 indexed citations

Hutchins, Jacob, Daniel J. Delaney, Rachel I. Vogel, et al.. (2015). Ultrasound guided subcostal transversus abdominis plane (TAP) infiltration with liposomal bupivacaine for patients undergoing robotic assisted hysterectomy: A prospective randomized controlled study. Gynecologic Oncology. 138(3). 609–613. 93 indexed citations

Felix, Ashley S., D. Scott McMeekin, David G. Mutch, et al.. (2015). Associations between etiologic factors and mortality after endometrial cancer diagnosis: The NRG Oncology/Gynecologic Oncology Group 210 trial. Gynecologic Oncology. 139(1). 70–76. 25 indexed citations

Dickson, Elizabeth L., Rachel I. Vogel, Melissa A. Geller, & Levi S. Downs. (2014). Cervical cytology and multiple type HPV infection: A study of 8182 women ages 31–65. Gynecologic Oncology. 133(3). 405–408. 69 indexed citations

Teoh, Deanna, et al.. (2014). Adherence to the 2012 national cervical cancer screening guidelines: a pilot study. American Journal of Obstetrics and Gynecology. 212(1). 62.e1–62.e9. 43 indexed citations

Dickson, Elizabeth L., Rachel I. Vogel, Xiaoqing Luo, & Levi S. Downs. (2014). Recent trends in type-specific HPV infection rates in the United States. Epidemiology and Infection. 143(5). 1042–1047. 20 indexed citations

Brinton, Louise A., Ashley S. Felix, D. Scott McMeekin, et al.. (2013). Etiologic heterogeneity in endometrial cancer: Evidence from a Gynecologic Oncology Group trial. Gynecologic Oncology. 129(2). 277–284. 144 indexed citations

10.

Saslow, Debbie, Diane Solomon, Herschel W. Lawson, et al.. (2012). American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology Screening Guidelines for the Prevention and Early Detection of Cervical Cancer. American Journal of Clinical Pathology. 137(4). 516–542. 613 indexed citations breakdown →

11.

Carter, Jori S. & Levi S. Downs. (2012). Vulvar and Vaginal Cancer. Obstetrics and Gynecology Clinics of North America. 39(2). 213–231. 14 indexed citations

12.

Geller, Melissa A., Joseph J. Ivy, Rahel Ghebre, et al.. (2011). A phase II trial of carboplatin and docetaxel followed by radiotherapy given in a “Sandwich” method for stage III, IV, and recurrent endometrial cancer. Gynecologic Oncology. 121(1). 112–117. 46 indexed citations

13.

Downs, Levi S., Isabel C. Scarinci, Mark H. Einstein, Yvonne Collins, & Lisa Flowers. (2010). Overcoming the barriers to HPV vaccination in high-risk populations in the US. Gynecologic Oncology. 117(3). 486–490. 74 indexed citations

14.

Downs, Levi S., Justin Chura, Peter A. Argenta, et al.. (2010). Ifosfamide, paclitaxel, and carboplatin, a novel triplet regimen for advanced, recurrent, or persistent carcinoma of the cervix: A phase II trial. Gynecologic Oncology. 120(2). 265–269. 12 indexed citations

15.

Geller, Melissa A., Levi S. Downs, Patricia L. Judson, et al.. (2010). Learning about ovarian cancer at the time of diagnosis: Video versus usual care. Gynecologic Oncology. 119(2). 370–375. 17 indexed citations

16.

Argenta, Peter A., Patricia L. Judson, Levi S. Downs, et al.. (2009). A phase II study of fulvestrant in the treatment of multiply-recurrent epithelial ovarian cancer. Gynecologic Oncology. 113(2). 205–209. 74 indexed citations

17.

Bradley, William H., et al.. (2007). Endometrial carcinoma expresses an increased cathepsin B/D ratio. Gynecologic Oncology. 108(1). 84–89. 8 indexed citations

18.

Downs, Levi S., Lisa M. Rogers, Yumi Yokoyama, & Sundaram Ramakrishnan. (2005). Thalidomide and angiostatin inhibit tumor growth in a murine xenograft model of human cervical cancer. Gynecologic Oncology. 98(2). 203–210. 9 indexed citations

19.

Judson, Patricia L., Melissa A. Geller, Robin Bliss, et al.. (2003). Preoperative detection of peripherally circulating cancer cells and its prognostic significance in ovarian cancer☆. Gynecologic Oncology. 91(2). 389–394. 60 indexed citations

20.

Downs, Levi S., Kris Ghosh, Kathryn E. Dusenbery, & Jonathan A. Cosin. (2002). Stage IV Carcinoma of the Bartholin Gland Managed with Primary Chemoradiation. Gynecologic Oncology. 87(2). 210–212. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact